Our blogger, Sue Trinidad, had posted about changes in testing for Down's syndrome before, but another interesting medical news item appeared today about a potential way to treat the cognitive deficits caused by Down's Syndrome: At the Society for Maternal-Fetal Medicine Meeting, investigators reported tha the learning deficits of mice with trisomy 21 appear to have been prevented with a peptide combination. Although the data and conclusions of the study should be considered to be preliminary as they have not yet been reviewed and published in a peer-reviewed publication, the results have sparked anticipation about the use of peptides in patients with Down's. And which raises an interesting ethical question to ponder: assuming that the therapies become safe and readily accessible, could there ever be a justification for a parent withholding such therapy?
Full article accessible here.
Showing posts with label trisomy 21. Show all posts
Showing posts with label trisomy 21. Show all posts
Tuesday, February 05, 2008
Subscribe to:
Comments (Atom)




